|
Recent Developments |
|
30-SEP-15
This follows a global transaction between GlaxoSmithKline plc, UK(GSK) and Novartis AG, Switzerland (Novartis) which was completed in March 2015 on the same basis, the company
06-NOV-14
GlaxoSmithKline Pharmaceuticals (GSK Pharma), a research-based pharmaceutical and healthcare company, reported a rose of 28% in net profit for the quarter ended September 2013.
12-AUG-14
Glaxo SmithKline Pharmaceuticals announced a sharp drop in st... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Period ending (months) | 31-Dec-2020(9) | 31-Mar-2020 (12) | 31-Mar-2019 (12) | | Net sales | 23864.60 | 32246.80 | 31285.30 | | Other Income | 805.80 | 775.60 | 1014.80 | | Total Income | 24670.40 | 33022.40 | 32300.10 | | Cost of goods sold | -19246.40 | -26552.50 | -25711.90 | | OPBDIT | 43916.80 | 59574.90 | 58012.00 | | PAT | 3448.10 | 1100.50 | 4253.60 | | Gross Block | - | - | - | | Equity capital | - | 0.00 | 0.00 | | EPS (Rs.) | - | 0.00 | 0.00 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | NA | NA | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 178.0 | 180.4 | 179.6 | | Net margin (% of OI) | 14.0 | 3.3 | 13.2 |
|
|
Detailed Financials
|
|
|
|
|
